WDCX surged approximately +12% in premarket trading on June 16, 2026, as the fund's 2x leverage amplified a roughly 6% premarket gain in its sole underlying holding, Western Digital Corp. (WDC). The primary catalyst is a powerful wave of Wall Street analyst price target upgrades, including Morgan Stanley raising its target on WDC by 33% to $650 and flagging the company's UltraSMR/HAMR storage roadmap as undervalued by the market.

ProShares Short Bitcoin ETF (BITI) gained approximately +25% over the past 30 days, driven primarily by a decline in Bitcoin prices. Over the past quarter, BITI advanced roughly +5%, reflecting a more moderate but sustained drop in the underlying cryptocurrency.

UVIX plunged 10.71% intraday, falling to $3.375 from a prior close of $3.78, as volatility expectations collapsed. The primary catalyst was a US-Iran interim peace deal that dramatically reduced geopolitical risk premiums across global markets.

Direxion Daily FTSE China Bear 3X Shares (YANG) rose approximately 26% over the past 30 days, driven primarily by weakness in Chinese equities. Over the past quarter, YANG gained about 5%, reflecting sustained pressure on the FTSE China 50 Index.

GDXD rose approximately +53% over the past 30 days, driven by its -3x inverse daily exposure to gold mining equities amid sector weakness. Over the past quarter, GDXD advanced roughly +22%, reflecting sustained underperformance in the underlying gold miners index.

Direxion Daily Healthcare Bull 3X Shares (CURE) rose approximately 14% over the past 30 days, driven primarily by gains in the underlying healthcare sector. Over the past quarter, CURE advanced roughly 5%, reflecting a recovery in healthcare equities amid broader market stabilization.

DFEN rose approximately 11% over the last 30 days, driven by gains in the underlying aerospace and defense sector. Over the past quarter, DFEN declined roughly 20%, reflecting broader volatility in leveraged defense exposure.

DPST gained approximately +17% over the past 30 days, driven primarily by strong performance in the regional banking sector. Over the last quarter, the ETF rose roughly +42%, reflecting broader recovery in financials amid improving economic signals.

CRCG is declining approximately -8% during Friday's regular trading session on June 12, 2026, as Circle Internet Group (CRCL) falls roughly -5% intraday from its June 11 close of $83.79. The primary driver is renewed interest rate sensitivity pressure on CRCL ahead of a critical week of U.S. inflation data releases, as the stablecoin operator's reserve income is directly tied to the level of short-term Treasury yields.

Oil supply dynamics from OPEC+ decisions and global production levels remain central drivers for the underlying crude oil futures index tracked by the ETF. Broader economic growth expectations and industrial demand for energy will shape the trajectory of WTI crude oil prices and, by extension, the inverse ETF’s positioning.

ASTX is declining approximately -15% during Friday's regular trading session on June 12, 2026, as AST SpaceMobile (ASTS) retreats sharply from its prior close of $97.56. The primary driver is a sharp reversal in ASTS shares, which surged +23.58% on June 11 and are now pulling back as profit-taking and sell-the-news dynamics dominate.

ADBG is declining approximately -15% in Friday's pre-market session on June 12, 2026. The primary catalyst is Adobe Inc. (ADBE) dropping -6.8% in pre-market trading following its Q2 FY2026 earnings report released after the close on June 11. Because ADBG is a 2x leveraged long ETF, a -6.8% decline in ADBE translates to an approximately double-magnitude loss for the fund.

RKLZ is declining approximately -8% in Friday's pre-market session on June 12, 2026. The primary catalyst is Rocket Lab Corporation (RKLB) surging more than 5–6% in pre-market trading, driven by a landmark announcement. Because RKLZ is a 2x leveraged inverse ETF, a rise in RKLB translates to a roughly double-magnitude decline in RKLZ.

UVIX is declining approximately 5% in premarket trading on June 11, 2026, falling from a prior session close of $4.61 to approximately $4.38, as a powerful risk-on wave suppresses volatility expectations. The primary catalyst is a sweeping shift in market sentiment driven by a bullish UBS research note forecasting a generational semiconductor boom, which has sent chip stocks sharply higher and compressed equity volatility expectations.

SOXL is trading up approximately 8.46% in premarket on June 11, 2026, from a prior session close of $180.65 to $195.93, driven by a broad semiconductor sector rally. The primary catalyst is a sweeping UBS research report published June 10 forecasting a generational semiconductor boom, projecting global chip industry revenues to reach $2.38 trillion by 2027 as agentic AI fuels explosive demand.

ORCX is down approximately 18% in premarket trading on June 11, 2026, reflecting a near-double amplification of Oracle Corporation's (ORCL) roughly 9–10% premarket decline. The primary catalyst is Oracle's fiscal Q4 2026 earnings report, which, despite beating Wall Street estimates, revealed a staggering $55.7 billion in capital expenditures and a new $40 billion capital raise plan that alarmed investors.

IONZ is trading approximately -10% lower during Wednesday's opening session on June 10, 2026, from a prior session close of $2.16 to approximately $1.94. As a 2x inverse ETF, IONZ declines when its underlying holding, IonQ (IONQ), rises — and IONQ is advancing sharply today, driving the ETF's fund performance deeply negative.

GDXU is trading approximately -10% lower in premarket on June 10, 2026, declining from a prior session close of $103.63 to approximately $93.27. The primary catalyst is a sharp selloff in gold prices, with spot gold collapsing below $4,200 per ounce — down -2.22% to $4,166.49 — on rising U.S. rate-hike expectations and a strengthening dollar.

OSCX is trading approximately +10% higher in premarket on June 10, 2026, with the fund's prior closing price near $97.23 and the premarket quote near $107.00. The primary catalyst is a Barclays analyst upgrade of Oscar Health (OSCR) on June 10, citing valuation upside potential and strengthening fundamental momentum. A secondary driver is continued positive market reaction to management's reaffirmation of full-year 2026 guidance at the Goldman Sachs Healthcare Conference, where Oscar Health cited "healthy tailwinds" and better-than-expected morbidity trends.

SMCX is trading approximately -23.12% lower in premarket on June 10, 2026, from a prior close of $30.23 to approximately $23.24. The primary catalyst is a severe premarket decline in Super Micro Computer (SMCI), the fund's sole underlying holding, which is under acute pressure from compounding legal and business headwinds.